Patents
Patents for C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
02/2002
02/05/2002US6344556 Thio containing monomers for polymers
01/2002
01/29/2002US6342608 Reacting organometallic reagent with activated carboxylic acid to form ketone, treating with mixture of carbon disulfide and dihalomethane to form dithietane, reacting with hydrazine derivative to form thiol-substituted pyrazole, alkylating
01/24/2002US20020009635 Novel materials for use as electrolytic solutes
01/23/2002CN1332155A Polyisocyanic acid ester
01/16/2002EP1172110A2 Use of lipoic acid as a bioavailaty enhancer of mineral salts
01/10/2002WO2002002533A1 Propane-1,3-dione derivatives
01/10/2002WO2001049250A3 Treatment of acne using lipoic acid
01/09/2002EP1169316A1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
12/2001
12/25/2001US6333428 Treatment or prevention of psychiatric disorders or neurological diseases
12/20/2001WO2001015693A3 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof
12/19/2001EP1164121A1 Novel carboxylic acid derivatives and process for producing the same
12/19/2001EP1163553A1 Oxime derivatives and the use thereof as photoinitiators
12/19/2001EP1163029A2 Nitrate esters and their use for inducing neuroprotection and cognition enhancement
12/18/2001US6331559 Lipoic acid derivatives and their use in treatment of disease
12/13/2001WO2001093865A2 Medicaments for treating dementia
12/13/2001WO2001093824A1 Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
12/13/2001WO2001049275A3 Methods and compositions for mitigating pain using nitrate esters
12/13/2001DE10027968A1 Adjuvant therapy of dementia using alpha-lipoic acid or derivative, is effective in combination with antidementia or neurotransmission improving agents in improving cognitive function in e.g. Alzheimer's disease patients
12/12/2001EP0889936B1 Cationically polymerizable compositions capable of being applied by electrostatic assistance
12/12/2001CN1326473A Supported group 8-10 transition metal olefin polymerization catalysts
12/11/2001US6329522 Glycosylating purine or pyrimidine base or analogue thereof with oxathiolan or dithiolan derivative in presence of lewis acid catalyst
12/06/2001WO2001092252A1 Sulfur compound and use thereof
12/06/2001DE10027102A1 Production of compounds having at least one -CF2-O- bridge, useful for liquid crystal displays, comprises reaction of a bis(alkylthio)carbenium salt with a hydroxyl group containing compound.
11/2001
11/27/2001US6322950 Activator compound generates chemical changes by light absorption of indene sensitizing dye and produces radicals, acids or bases; and compound whose physical or chemical characteristics are changed product
11/27/2001CA2041835C Cyclohexenone oxime ethers, their preparation and their use as herbicides
11/22/2001WO2001009118A3 Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement
11/22/2001US20010044443 Fungicidal active compound combinations
11/21/2001CN1074902C Fungicidal active compound composition
11/20/2001US6319930 Substituted dimeric compounds
11/15/2001WO2001085677A1 Amino acid derivatives and their use as medicines
11/15/2001WO2001085165A2 Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system
11/15/2001DE10022856A1 Treating central nervous system disorders e.g. cognitive deficiency or depression, using combination of lipoic acid and C-1 donor e.g. S-adenosyl-methionine
11/15/2001CA2408666A1 Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system
11/15/2001CA2407830A1 Amino acid derivatives and their use as medicines
11/08/2001WO2001083571A2 Catalysts containing n-pyrrolyl substituted nitrogen donors
11/08/2001US20010039292 Lipoic acid analogs
11/08/2001CA2407692A1 Catalysts containing n-pyrrolyl substituted nitrogen donors
11/07/2001EP1151021A1 Initiator compositions and methods for their synthesis and use
11/06/2001US6313316 Polyisocyanate compounds, process for producing the same, and optical materials using the same
11/06/2001US6313173 Glyoxylic acid amides
11/06/2001US6313164 Dithiolin derivatives, their preparation and their therapeutic effect
11/06/2001US6313160 Substituted heterocyclic compounds, method for preparing and compositions containing same
11/06/2001US6313109 Prenyl transferase inhibitors
11/06/2001US6313075 Alkylated thianthrene lubricants
11/01/2001WO2001080856A2 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity
11/01/2001CA2406998A1 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity
10/2001
10/31/2001EP1149885A1 Cyclohexane derivatives, liquid crystal compositions comprising the same and liquid crystal display devices
10/31/2001EP1149830A1 Process for production of sulfur compounds
10/30/2001US6310080 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/30/2001US6310074 Substituted dimeric compounds
10/30/2001US6310052 Nitrate esters and their use for neurological conditions
10/23/2001US6307062 (Thio) (meth) acrylate monomers, intermediate compounds for the synthesis of these monomers, polymerisable compositions and polymers obtained, and their optical and ophthalmic uses
10/18/2001WO2000035903A3 Thiochromanoyl cyclohexenone derivatives
10/18/2001EP1144401A3 Thiochromanoyl cyclohexenone derivatives
10/17/2001EP1144401A2 Thiochromanoyl cyclohexenone derivatives
10/17/2001EP0854852B1 Cyclopentane-1,3-dione derivatives
10/16/2001US6303720 Olefin polymerization catalysts containing group 8-10 transition metals, processes employing such catalysts and polymers obtained therefrom
10/10/2001EP1140895A2 Thiopyran compounds as inhibitors of mmp
09/2001
09/27/2001US20010025007 Contacting one or more olefin monomers with a Group 8-10 transition metal complex catalyst and optionally a Bronsted or Lewis acid
09/26/2001EP0934252B1 Amide derivatives and their use as pesticides
09/26/2001EP0901486B1 Novel (thio)(meth)acrylate monomers, intermediate compounds for the synthesis of these monomers, polymerisable compositions and resulting polymers and optical and ophthalmologic applications thereof
09/20/2001WO2001068643A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
09/20/2001WO2001068575A1 Fluoroalkylonium salt type cation or acid generator generating cation or acid upon irradiation with energy ray
09/20/2001CA2402898A1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
09/19/2001EP1133487A1 Scavenger compounds
09/19/2001EP0675712B1 Reduction of hair growth employing sulfhydryl reactive compounds
09/12/2001EP1131318A1 Process for making 5-substituted pyrazoles using dithietanes
09/12/2001CN1070891C Composition for optical waterals and use thereof
09/11/2001US6288106 Administering a metal-alpha-lipoic acid as a hypotensive agent, antidiabetic agents and vasoconstrictors, and to treat vision defects, alzheimer*s disease, parkinson*s disease, cardiovascular disorders and brain disorders
09/07/2001WO2001064667A1 Producing liquid crystals with cf2o bond
09/06/2001DE10010537A1 Production of compounds having at least one -CF2-O- bridge, useful for liquid crystal displays, comprises reaction of a bis(alkylthio)carbenium salt with a hydroxyl group containing compound.
09/05/2001EP0574510B1 2,4-diaryl-1,3-dithiolanes as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
09/05/2001CN1311784A Crystal modification of lipoic acid
09/04/2001US6284787 Use of R-(+)-α-lipoic acid, R-(−)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae
08/2001
08/29/2001CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions
08/28/2001US6281214 Biphenyl derivatives
08/22/2001EP1124820A1 Lipoic acid derivatives and their use in treatment of disease
08/16/2001US20010014646 Bidentate ligands bonded to nickel, palladium, cobalt, or iron, and optionally, one or more neutral Lewis acids
08/09/2001US20010012596 Oxime ester photoinitiators
08/08/2001CN1307572A Cyclohexenondioxothio chromanoyl derivatives
08/07/2001US6271396 Use of organosulfur compounds for effecting a bathocromic shift in the UV/vis absorption bands of carotenoids
08/07/2001US6271254 Producing cytoprotective effect in a person via administering isomers of alpha-lipoic acid on carriers (stabilizers and solubilizers); useful in treating pain and inflammation
07/2001
07/12/2001WO2001049275A2 Methods and compositions for mitigating pain using nitrate esters
07/12/2001WO2001049250A2 Treatment of acne using lipoic acid
07/12/2001CA2394184A1 Methods and compositions for mitigating pain using nitrate esters
07/12/2001CA2362453A1 Treatment of acne using lipoic acid
07/10/2001US6258775 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
07/05/2001WO2001047911A1 Cationic amphiphiles, uses and synthesis method thereof
06/2001
06/27/2001EP1110943A1 6-fluorobicyclo 3. 1.0]hexane derivatives
06/27/2001CN1301156A Treatment of T-Helper cell tyre 2 mediated immune diseases with retinoid antagonists
06/26/2001US6251935 Administration of a racemic alpha-lipoic acid, enantiomers and pharmaceutically acceptable salts, amides, esters or thioester, in reduced or oxidized form as antimigraine agent
06/21/2001DE10061947A1 Oximester-Photostarter Oxime ester photoinitiator
06/20/2001CN1299812A Oximate light initiator
06/15/2001CA2328376A1 Oxime ester photoinitiators
06/12/2001US6245871 Group 8-10 transition metal olefin polymerization catalysts
06/12/2001US6245811 Fatty acid esters as bioactive compounds
06/12/2001CA2080917C New pharmacologically active catechol derivatives
06/07/2001WO2001040874A1 Use of a composition in stereolithography
06/07/2001WO2001040175A1 Process for production of sulfur compounds
06/05/2001US6242612 Multistage reaction of forming pyrazoles as kinase and cox-2 enzyme inhibitors
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 34